ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2015

Feb 18, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2015-02-17

Reporting Person: RITTER DALE (Vice President - Finance)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$4.342	2024-08-28	Common Stock (43982)		Direct

Footnotes

F1: These options shall vest 25% on August 29, 2015, and the remainder shall vest in equal monthly installments thereafter over 36 months, provided, that no portion of this stock option shall become vested and exercisable until the consummation of the issuer's initial public offering.